CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery
CDT Equity Inc. (CDT)
Company Research
Source: GlobeNewswire
NAPLES, Fla. and CAMBRIDGE, United Kingdom, April 16, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today provides a strategic update outlining its positioning as a multi-pathway value creation business spanning a pharmaceutical asset portfolio, proprietary solid-form intellectual property and artificial intelligence-driven indication discovery. The Company believes it is uniquely positioned through a combination of high-quality clinical assets, proprietary chemistry, and advanced data-driven capabilities to generate long-term shareholder value through a capital-efficient, out-licensing model. CDT continues to evaluate and advance its portfolio of assets licensed from AstraZeneca, including AZD1656, AZD5658 and AZD5904, which benefit from extensive clinical validation and established safety profiles, through combination therapies and novel indications. These assets are a strong foundation for partnership, supported by CDT’s ongoing solid-form a
Show less
Read more
Impact Snapshot
Event Time:
CDT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CDT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CDT alerts
High impacting CDT Equity Inc. news events
Weekly update
A roundup of the hottest topics
CDT
News
- CDT Notes Sarborg Publication of PRISM Framework Expanding AIGlobeNewswire
- CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent FilingsGlobeNewswire
- CDT Equity Inc. Announces Reverse Stock SplitGlobeNewswire
- CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing StrategyGlobeNewswire
- CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth [Yahoo! Finance]Yahoo! Finance
CDT
Sec Filings
- 4/15/26 - Form 10-K
- 4/2/26 - Form 424B5
- 4/1/26 - Form NT
- CDT's page on the SEC website